What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?

Developmental Medicine and Child Neurology

Volumn 53, Issue 6, 2011, Pages 485-

  Barrett, Rod S ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

CEREBRAL PALSY; GAIT DISORDER; HUMAN; LONG TERM CARE; MOTOR PERFORMANCE; MUSCLE GROWTH; MUSCLE MASS; NOTE; PRIORITY JOURNAL; RANGE OF MOTION; SPASTICITY;

BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; HUMANS; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS;

EID: 79955983363     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2011.03950.x     Document Type: Note

References (5)

1. Love SC, Novak I, Kentish M, et al. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. Eur J Neurol 2010; 17(Suppl. 2): 9-37.
2. Alhusaini A, Crosbie J, Shepherd R, Dean C, Scheinberg A. No change in calf muscle passive stiffness following Botulinum toxin injection in children with cerebral palsy. Dev Med Child Neurol 2011; 53: 553-58. DOI:.
3. Fortuna R, Vaz M, Youssef A, Longino D, Herzog W. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox). J Biomech 2011; 44: 39-44.
4. Barber L, Hastings-Ison T, Baker R, Barrett RS, Lichtwark GA. Medial gastrocnemius muscle volume and fascicle length in children aged 2 to 5 years with cerebral palsy. Dev Med Child Neurol 2011; 53: 543-48. DOI:.
5. Damiano DL, Arnold AS, Steele KM, Delp SL. Can strength training predictably improve gait kinematics? A pilot study on the effects of hip and knee extensor strengthening on lower-extremity alignment in cerebral palsy. Phys Ther 2010; 90: 269-79.